tiprankstipranks
Hepion Pharmaceuticals (HEPA)
NASDAQ:HEPA

Hepion Pharmaceuticals (HEPA) Ownership - Who Owns Hepion Pharmaceuticals?

700 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 28, 2023Bought$15350
Sep 20, 2023Bought$16841
Sep 19, 2023
Robert T Foster
Ceo And Director
Bought$8960
Sep 18, 2023
Robert T Foster
Ceo And Director
Bought$8640

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
152,913Institution2.79%322,799
152,913Institution2.79%322,799
32,324Institution0.59%68,236
3,104Institution0.06%6,553
2,985Institution0.05%6,301
1,577Institution0.03%3,329
501Institution<0.01%1,058
422Institution<0.01%891

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
152,913Institution2.79%322,799
32,324Institution0.59%68,236
3,104Institution0.06%6,553
2,985Institution0.05%6,301
1,577Institution0.03%3,329
501Institution<0.01%1,058
422Institution<0.01%891

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
104,005Institution1.90%258,972
48,908Institution0.89%121,781

FAQ

Who Owns Hepion Pharmaceuticals (HEPA)?
Currently, no data Available
What percentage of Hepion Pharmaceuticals (HEPA) stock is held by institutional investors?
Currently, no data Available
What percentage of Hepion Pharmaceuticals (HEPA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Hepion Pharmaceuticals (HEPA)?
Vanguard owns the most shares of Hepion Pharmaceuticals (HEPA).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis